Land: Australië
Taal: Engels
Bron: APVMA (Australian Pesticides and Veterinary Medicines Authority)
APOMORPHINE HYDROCHLORIDE
JUROX PTY LIMITED
apomorphine HCl(6.5mg/Tb)
ORAL TABLET
APOMORPHINE HYDROCHLORIDE ALKALOID Active 6.5 mg/Tb
20 Tablets
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
CENTRAL NERVOUS SYSTEM
EMETIC | INDUCE VOMITING
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [EMETIC]; An emetic for use in dogs.
Registered
2023-07-01
JUROX APOMORPHINE EMETIC TABLETS 48380/12 3719 Product Name: APVMA Approval No: Label Name: JUROX APOMORPHINE EMETIC TABLETS Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: Each tablet contains 6.5 mg APOMORPHINE HYDROCHLORIDE Claims: Label: An emetic for use in dogs. Leaflet: An emetic for use in dogs, working directly on the CNS vomiting centre. Vomiting usually occurs within 5 minutes after administration and can last for 20 to 25 minutes. Net Contents: 20 tablets Directions for Use: Restraints: Contraindications: DO NOT USE in cats, rodents or rabbits. DO NOT USE in dogs hypersensitive to morphine. DO NOT USE in dogs which have ingested sharp objects, strong acids, alkalis or caustic agents because of the risk for additional oral, oesophageal or gastric injury with emesis. DO NOT USE in dogs which are hypoxic, dyspnoeic, in shock, seizuring, comatose, severely depressed, lacking normal pharyngeal reflexes, or which have displayed protracted vomiting, due to increased risk of aspiration. DO NOT USE in dogs which have ingested petroleum distillates due to risks associated with aspiration. Precautions: Apomorphine administration following poisoning with strychnine or other CNS stimulants may precipitate seizures. Care should be used when treating poisoning cases caused by CNS depressants due to the possible summation of effects. The safety of this drug has not been established during pregnancy and lactation in dogs. RLP APPROVED Side Effects: Sedation and tachycardia are common following apomorphine administration in dogs. Hypersalivation and protracted vomiting can occur in dogs, which may be treated with maropitant or metoclopramide. Eye redness / irritation after ophthalmic administration is possible; flushing the conjunctiva with sterile saline after emesis is recommended. Overdose may result in respiratory and / or cardiac depression, hypotension, CNS stimulation (excitement, seizures) or depression. Naloxone may reverse the CNS and Lees het volledige document
APOMORPHINE EMETIC TABLETS Page 1 of 5 continued ISSUED: 15 AUGUST 2012 SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY PRODUCT NAME: APOMORPHINE EMETIC TABLETS PRODUCT CODE: 500490 (20 tablets) RECOMMENDED USE: An emetic for use in dogs COMPANY IDENTIFICATION: Jurox Pty Limited ADDRESS: 85 Gardiner Street Rutherford NSW 2320 Australia CUSTOMER CENTRE: 1800 023 312 NATIONAL POISONS INFORMATION CENTRE: 131126 (Australia-wide) EMERGENCY TELEPHONE NUMBER: 1800 023 312 (9a.m. – 5p.m.) SECTION 2: HAZARDS IDENTIFICATION GHS HAZARD CLASSIFICATIONS: RESPIRATORY SENSITISER CATEGORY 1 SKIN SENSITISER CATEGORY 1 GHS PICTOGRAM: EXCLAMATION MARK HEALTH HAZARD SIGNAL WORD:* DANGER HAZARD STATEMENTS:* H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. PRECAUTIONARY STATEMENTS:* PREVENTION P261 Avoid breathing dust. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves e.g. PVC or vinyl and protective eyewear e.g. Safety glasses with eye side shields or chemical goggles. P285 In case of inadequate ventilation wear respiratory protection. RESPONSE P302+P352 IF ON SKIN: Wash with plenty of soap and water. P304+P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor. P363 Wash contaminated clothing before reuse. DISPOSAL P501 Dispose of contents/container in accordance with local/national regulations. * N.B.: These statements are determined by Work Health and Safety regulations and may not reflect Signal Headings and First Aid and Safety statements on product labelling, which are determined by a competent authority. APOMORPHINE EMETIC TABLETS Page 2 of 5 continued SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS INGREDIENT CAS NO. CONTENT Apomorphine hydroch Lees het volledige document
WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL ACTIVE CONSTITUENTS Apomorphine hydrochloride 6.5 mg / tablet PROPERTIES Apomorphine Tablets are an emetic for use in dogs. Apomorphine is an agonist of D1 and D2 receptors in the central nervous system. Vomiting usually occurs within 5 minutes after administration and can last for up to 25 minutes. INDICATIONS Induction of emesis. PRECAUTIONS Do NOT use in cats. Do NOT use in dogs which have ingested strong acids, alkalis or caustic agents. Do NOT use in dogs which are hypoxic, dyspnoeic, in shock, seizuring, comatose or severely depressed. Do NOT use in dogs which lack normal pharyngeal reflexes or which have displayed protracted vomiting. Apomorphine administration following poisoning with strychnine or other CNS stimulants may precipitate seizures. Do NOT administer a second dose if the first dose fails to produce emesis. Due to the possible summation of effects, care must be taken when treating poisoning cases caused by CNS depressants. Overdosage is characterised by rapid respiration, running in circles or tetanic convulsions and can be treated by a phenothiazine derivative such as chlorpromazine.¹ Haloperidol is a known potent antagonist to apomorphine.² APOMORPHINE Emetic Tablets WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL DIRECTIONS FOR USE FOR CONJUNCTIVAL OR ORAL ADMINISTRATION 0.25 mg/kg (1 tablet/26 kg) Place the tablet under the conjunctiva or give orally FOR SUBCUTANEOUS ADMINISTRATION Dissolve the tablet in 20 mL Water for Injections or sterile saline or equivalent (0.325 mg/mL) Dose at 0.08 mg/kg (0.246 mL/kg) FOR INTRAVENOUS ADMINISTRATION Dissolve the tablet in 20mL Water for Injections or sterile saline or equivalent (0.325 mg/mL) Dose at 0.04 mg/kg (0.123 mL/kg) PRESENTATION 20 tablets in plastic vial with label containing a light protective coating. STORAGE Store below 30°C (room temperature). Protect from light, moisture and air. POISONS Lees het volledige document